February 22, 2001Two Lots of Premarin® Recalled
TN (SafetyAlerts) - The Food and
Drug Administration (FDA) said today that McKesson HBOC is recalling certain
lots of PremarinÆ tablets because of manufacturerís dissolution failure.
This is the first public notice of
this Class III
recall issued by FDA.
a)PremarinÆ tablets (conjugated estrogens tablets), 1.25mg, 1,000
count. Recall #D-093-1.
b)PremarinÆ tablets (conjugated estrogens tablets), 2.5mg, 100 count
bottles. Recall #D-094-1.
a) LOT NOS. 00344, Exp. Date: 08/03; and 01065, Exp. Date: 02/04;
b) LOT NOS. 00430, Exp. Date: 10/03.
Ayerst Laboratories, Div. Of Wyeth-Ayerst Pharmaceuticals, Inc., Rouses Point, NY. And
Wyeth Pharmaceuticals Co., Guayama, Puerto Rico.
McKesson HBOC, Memphis, TN., by intranet on October 23, 2000 and December 13, 2000.
Firm-initiated recall ongoing.
Ninety wholesalers within the United States.
a) Lot 00344: 1,198 bottles; Lot 01065: 2,388 bottles.
b) Lot 00430: 2,932 bottles.
Questions concerning this recall may be directed
to the FDA at 1-888-INFO-FDA.
Notice of this product warning was sent via email
to SafetyAlerts subscribers February
22, 2001. For more information regarding the SafetyAlerts free email alert service
please click here.
comprehensive safety recall information for the United States. SafetyAlerts Newsletter is a free email service to warn
consumers of faulty products and contaminated foods. For complete information regarding
current recalls, past recalls and timely product warning notification visit: www.safetyalerts.com.